Abstract
The latter half of the twentieth century witnessed a global expansion in the prevalence of diabetes. This expansion resulted from generally increasing life expectancy, and from ‘diabetogenic’ lifestyles and environments associated with reduced physical activity and increased calorie intake. All stages of the development of type 2 diabetes are associated with raised risk of cardiovascular disease, a fact that threatens to reverse the improving trend in cardiovascular mortality of recent decades in most world populations. At the same time, the incidence of the less common type 1 diabetes (which is usually triggered by auto-immune mechanisms) also increased.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
An ‘off the record’ comment from a qualitative research participant with type 1 diabetes, University of Warwick, 2004.
References
World Health Organization. Definition, diagnosis and classification of diabetes mellitus. Report of a WHO consultation. Geneva: WHO; 1999.
Farmer A, Fox R. Diagnosis, classification, and treatment of diabetes. BMJ. 2011;342:d3319. doi:10.1136/bmj.d3319.
Glass L, Kaplan D. Time series analysis of complex dynamics in physiology and medicine. Med Prog Technol. 1993;19(3):115–28.
Schaffer WM. Order and chaos in ecological systems. Ecology. 1986;66(1):93–106.
Farmer A, Wade A, Goyder E, et al. Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial. BMJ. 2007;335:132.
Tattersall R. Diabetes: the biography. Oxford: Oxford University Press; 2009.
Bolli GB. Physiological insulin replacement in type 1 diabetes mellitus. Exp Clin Endocrinol Diabetes. 2001;109 suppl 2:S317–32.
Shima K, Tanaka R, Morishita S, Tarui S, Kumahara Y, Nishikawa M. Studies on the etiology of ‘brittle diabetes’. Relationship between diabetic instability and insulinogenic reserv. Diabetes. 1977;28:717–25.
DAFNE Study Group. Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial. BMJ. 2002;325:746.
Speight J, Amiel SA, Bradley C, Heller S, Oliver L, Roberts S, Rogers H, Taylor C, Thompson G. Long-term biomedical and psychosocial outcomes following DAFNE (Dose Adjustment For Normal Eating) structured education to promote intensive insulin therapy in adults with sub-optimally controlled type 1 diabetes. Diabetes Res Clin Pract. 2010;89:22–9.
Holt T, Kumar S, editors. ABC of diabetes. 6th ed. Oxford: Wiley Blackwell; 2010. p. 44–5.
Plsek PE, Wilson T. Complexity science: complexity, leadership, and management in healthcare organisations. BMJ. 2001;323:746.1.
Monnier L, Colette C. Glycemic variability: should we and can we prevent it? Diabetes Care. 2008;31 Suppl 2:S150–4.
Flake GW. The computational beauty of nature: Computer explorations of fractals, chaos, complex systems, and adaptation. Cambridge: MIT Press; 1996. p. 226–7.
Lorenz E. Deterministic non-periodic flow. J Atmos Sci. 1963;20:130–41.
Sparacino G, Facchinetti A, Cobelli C. Smart continuous glucose monitoring sensors: on-line signal processing issues. Sensors. 2010;10:6751–72.
Pickup JC, Freeman SC, Sutton AJ. Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data. BMJ. 2011;343:d3805.
Ceriello A, Hanefeld M, Leiter L, Monnier L, Moses A, Owens D, Tajima N, Tuomilehto J. Postprandial glucose regulation and diabetic complications. Arch Intern Med. 2004;164:2090–5.
Monnier L, Colette C, Owens DR. Glycemic variability: the third component of the dysglycemia in diabetes. Is it important? How to measure it? J Diabetes Sci Technol. 2008;2:1094–100.
Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, Colette C. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA. 2006;295(14):1681–7.
Kaplan D, Glass L. Understanding non-linear dynamics. New York, NY: Springer; 1995. p. 295–7.
Bremer T, Gough DA. Is blood glucose predictable from previous values? A solicitation for data. Diabetes. 1999;48:445–51.
Kroll MH. Biological variation of glucose and insulin includes a deterministic chaotic component. Biosystems. 1999;50:189–201.
Peng CK, Havlin S, Stanley HE, Goldberger AL. Quantification of scaling exponents and crossover phenomena in nonstationary heartbeat time series. Chaos. 1995;5:82–7.
Ogata H, Tokuyama K, Nagasaka S, Ando A, Kusaka I, Sato N, Goto A, Ishibashi S, Kiyono K, Struzik ZR, Yamamoto Y. Long-range negative correlation of glucose dynamics in humans and its breakdown in diabetes mellitus. Am J Physiol Regul Integr Comp Physiol. 2006;291:R1638–43.
Khovanova NA, Khovanov IA, Sbano L, Griffiths F, Holt TA. Characterization of linear predictability and non-stationarity of subcutaneous glucose profiles. Computer Methods and Programs in Biomedicine, (in press).
Lean MEJ, Pearson DWM, Sutherland HW. Insulin management during labour and delivery in mothers with diabetes. Diabet Med. 1990;7:162–4.
Wilson T, Holt T, Greenhalgh T. Complexity science: complexity and clinical care. BMJ. 2001;323:685.1.
Queale WS, Seidler AJ, Brancati FL. Glycemic control and sliding scale insulin use in medical inpatients with diabetes mellitus. Arch Intern Med. 1997;157:545–52.
Garfinkel A, Spano ML, Ditto WL, et al. Controlling cardiac chaos. Science. 1992;257:1230–5.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Holt, T.A. (2013). Diabetes Control: Insights from Complexity Science. In: Sturmberg, J., Martin, C. (eds) Handbook of Systems and Complexity in Health. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-4998-0_20
Download citation
DOI: https://doi.org/10.1007/978-1-4614-4998-0_20
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-4997-3
Online ISBN: 978-1-4614-4998-0
eBook Packages: MedicineMedicine (R0)